Strong New Leadership


    


Buisness Wire: National Cancer Center Names Michelle Stack CEO Following Retirement of Long-Time Leader Regina English

Stack will lead the 70-year-old nonprofit through the next phase of development, which includes new fundraising channels and greater national impact

NEW YORK–(BUSINESS WIRE)–The Board of National Cancer Center is pleased to announce that Michelle Stack has joined as CEO. Ms. Stack replaces long-time leader Regina English, who is now Executive Director Emerita and Board member-at-large.

Ms. Stack brings to the position leadership roles in corporate fashion and beauty as well as a highly successful track record of fundraising for nonprofit organizations.

“We are delighted to name Michelle as CEO of National Cancer Center,” said Barry Peek, President of the Board. “She is the right leader at the right time. Her rich experience in both corporate and nonprofit organizations and her tremendous energy will help NCC broaden and deepen its mission of funding early-stage research with the promise of curing of cancer.”

“She is the right leader at the right time. Her rich experience in both corporate and nonprofit organizations and her tremendous energy will help NCC broaden and deepen its mission of funding early-stage research with the promise of curing of cancer.”

He added: “Without Ms. English’s wise and creative leadership, NCC would not be in the strong position it enjoys today, and the Board is deeply grateful for her many contributions to the organization. We are proud of the work NCC has done over the past 70 years and are energized about the opportunities ahead.”

Ms. Stack said: “It is an exciting time for cancer studies and novel explorations. I am honored to be a part of this incredible organization and this dedicated and respected team. I know that together, we can make remarkable things happen and continue funding tomorrow’s research today.”

Now celebrating its 70th year, NCC is dedicated to providing financial support to research with the promise of conquering cancer. NCC runs six cancer research programs: Aggressive Cancer Project; Fighting Childhood Leukemia; The Breast Cancer Project; Children’s Cancer Project; Prostate Cancer Project and the NCC Project, which funds research showing particular promise in the following areas: brain tumors, melanoma, DNA repair, anti-cancer therapies, gene mutations and targeted therapeutics for breast cancer.


In 2023, NCC gave six new fellowships and nine renewals totaling $768,000 to recipients working on promising early-stage research to cure cancer. The organization also provides education on the prevention, diagnosis and treatment of cancer.

READ FULL ARTICLE